Join
Live feed
·
SECFilingvia Quantisnow
Terns Pharmaceuticals Inc. logo

Terns Pharmaceuticals Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Completion of Acquisition or Disposition of Assets, Material Modification to Rights of Security Holders, Leadership Update

ByQuantisnow·Wall Street's wire, on your screen.
TERN· Terns Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TERN (Terns Pharmaceuticals Inc.) and more on Quantisnow.

Terns Pharmaceuticals Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Completion of Acquisition or Disposition of Assets, Material Modification to Rights of Security Holders, Leadership Update | Quantisnow